Chairman & CEO
Ethan Shen, PhD
Founder, Chairman, and CEO of YD Biopharma, JY Biomedical, and EG Biomed
Dr. Ethan Shen is an accomplished entrepreneur and academic leader with a commitment to advancing global healthcare through innovation and excellence. With more than two decades of experience in biotechnology, translational medicine, and leadership, Dr. Shen has built a distinguished reputation in the field.
“At YD Biopharma, we believe in the potential of science to shape a healthier future. Together, we aim to advance healthcare innovation and deliver meaningful solutions to those with the greatest needs.”

Academic Excellence
PhD in Translational Medicine (2024)
Academia Sinica and Taipei Medical University (Top 250 in Clinical and Health studies).
EMBA (2016)
Fudan University (Global Rank: 36) and National Taiwan University (Global Rank: Top 125 in Business and Economics).
Graduate Certificate in Financial Research (2006)
City University of New York, Baruch College.
Bachelor of Pharmacy (2000)
Taipei Medical University.

Professional Achievements
Secured 10 patents and over USD$125,000 in research grants.
Published research in high-impact journals such as Biomolecules and Cancers.
Served Top 10 global pharmaceutical companies, including Roche, Novartis, Sandoz, and Alcon.

Entrepreneurial Ventures
YD Biopharma
Evolving from a supplier of investigational drugs for clinical trials to a developer of precision medicine and exosome-based therapies.
JY Biomedical
Advancing the research and development of cancer vaccines, cell therapies, and antibody programs in collaboration with Hexun Biosciences and 3D Global Biotech.
EG Biomed
Developing early cancer detection solutions using liquid biopsy technologies with high analytical sensitivity, supported by collaboration with Taipei Medical University.

Philanthropy and Leadership
YuDing Global Cancer Research Foundation
Awarded USD$25,000 in research grants since 2022.
Taiwan Chronic Disease Healthcare Association
Founded in 2016, growing to 89 members, advancing chronic disease care.
